| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 04/03/2003 | WO2002101101A3 Solvent extraction mixture comprising substituted imidazole or benzimidazole for the purification of base metals |
| 04/03/2003 | WO2002058632A3 Primary intermediates for oxidative coloration of hair |
| 04/03/2003 | US20030065195 Ether compounds |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065176 Anticoagulant; cardiovascular disorders |
| 04/03/2003 | US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis |
| 04/03/2003 | US20030065014 Substance for inducing apoptosis |
| 04/03/2003 | US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents |
| 04/03/2003 | US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/03/2003 | US20030064980 Respiratory system disorders; antiinflammatory agents |
| 04/03/2003 | US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/03/2003 | CA2461603A1 Substituted amines for the treatment of neurological disorders |
| 04/02/2003 | EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/02/2003 | EP1296977A1 Heteroaryl-phenyl substituted factor xa inhibitors |
| 04/02/2003 | EP1296931A2 Polyamine analogues as cytotoxic agents |
| 04/02/2003 | EP0951485B1 Method of controlling polymer molecular weight and structure |
| 04/02/2003 | EP0885189B9 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 04/02/2003 | EP0880518B1 A process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives |
| 04/02/2003 | EP0880504B1 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 04/02/2003 | EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
| 04/02/2003 | EP0632028B1 Optically active 2-nitroimidazole derivative, process for producing the same, and intermediate for producing the same |
| 04/02/2003 | CN1407968A Adamantane derivatives |
| 04/02/2003 | CN1104421C Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/02/2003 | CN1104420C Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl) phenyl)-4-methyl-2,5-imidazolidin-1-yl) acetylamino)-3-phenyl propionate |
| 04/02/2003 | CN1104413C Phenylalkylcarboxylic acid derivatives |
| 04/02/2003 | CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
| 04/01/2003 | US6541658 Process for synthesis of (meth) acrylic acid esters by transesterification in the presence of mixed catalysts containing alkali metal cyanate or thiocyanate |
| 04/01/2003 | US6541639 Efficient ligand-mediated Ullmann coupling of anilines and azoles |
| 04/01/2003 | US6541635 Silylprotected L-proline derivative or salt is deprotected in presence of a nonaqueous medium containing an organic solvent at a temperature of 5 degree C. to 40 degree C. |
| 04/01/2003 | US6541486 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/27/2003 | WO2003024955A2 Small molecule inhibitors of caspases |
| 03/27/2003 | WO2003024529A1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2002048157A3 Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors |
| 03/27/2003 | WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents |
| 03/27/2003 | US20030060653 N-unsubstituted amidinium salts |
| 03/27/2003 | US20030060492 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
| 03/27/2003 | US20030060485 (+)-norcisapride |
| 03/27/2003 | US20030060452 N-heterocyclic derivatives as NOS inhibitors |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/27/2003 | CA2460244A1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1295880A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts |
| 03/26/2003 | EP1295874A2 Retroviral protease inhibiting compounds |
| 03/26/2003 | EP1294722A2 Methods of synthesis for 9-substituted hypoxanthine derivatives |
| 03/26/2003 | EP1294699A2 Modulators of tnf- alpha signalling |
| 03/26/2003 | EP1294691A1 Serine protease inhibitors |
| 03/26/2003 | EP0998454B1 Metalloproteinase inhibitors |
| 03/26/2003 | EP0885186B1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 03/26/2003 | CN1405144A 由海龙科动物提取的海龙素及其制法和用途 Dragon species extracted by Dragon hormone preparation and use |
| 03/26/2003 | CN1103775C Vitronectin receptor antagonists, their preparation and use |
| 03/26/2003 | CN1103762C Novel 1-ar (alk) yl-imidazolin-2-ones contg. a disubstituted amine radical in the 4th position having an anti-convulsive effect, and production method thereof |
| 03/26/2003 | CN1103761C Process for producing 1-substituted-hydantoins |
| 03/26/2003 | CN1103760C 1,3-dihydro-2H-imidazol-2-one derivatives having PDEIV and cytokinin inhibiting activity |
| 03/25/2003 | US6538143 Reaction product of vinyl ethylene carbonate, methacryloxypropylene carbonate, and allyloxypropylene carbonate; and alkyl or cyclic urea |
| 03/25/2003 | US6537329 Intense colorations with a wide range of colours, excellent colorfastness |
| 03/20/2003 | WO2003022820A1 Heteroaromatic substituted cyclopropane as corticotropin releasing hormone |
| 03/20/2003 | WO2003022812A1 Organic sulfates as ionic liquids |
| 03/20/2003 | WO2003022795A1 Method for producing beta-alanine amides |
| 03/20/2003 | WO2003000662A8 Chiral preparation of a diastereomeric compound |
| 03/20/2003 | WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 03/20/2003 | US20030055266 Small molecule modulators of G protein-coupled receptors |
| 03/20/2003 | US20030055263 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production |
| 03/20/2003 | US20030055247 Thiazolyl(pyridyl)ethyne compounds |
| 03/20/2003 | US20030055100 Cytotoxic compounds |
| 03/20/2003 | US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 03/20/2003 | US20030055086 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 03/20/2003 | US20030055064 Piperazine compounds and medicinal use thereof |
| 03/20/2003 | US20030054507 Process for the preparation of the enant iomeric forms of 2-substituted 2- (2, 5-dioxoimidazolidin-1-yl) -acetic acid derivatives |
| 03/20/2003 | US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials |
| 03/19/2003 | EP1293508A1 Organometallic precursor for forming metal pattern |
| 03/19/2003 | EP1293502A1 Process for the preparation of (meth)acrylates of alkylimidazolidone |
| 03/19/2003 | EP1292578A1 Para-aminophenol derivatives and their use as developers for producing oxidation colorations |
| 03/19/2003 | EP1292573A2 Substituted thioacetamides |
| 03/19/2003 | EP0888309B1 Imidazole derivatives having affinity for alpha2 receptors activity |
| 03/19/2003 | CN1404496A Organic polymer and novel polymerizable compound |
| 03/19/2003 | CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 03/18/2003 | US6534627 Synthesis and use of amino acid fluorides as peptide coupling reagents |
| 03/18/2003 | US6534532 Carbanilides as pesticides |
| 03/18/2003 | US6534522 Subtype-selective NMDA receptor ligands and the use thereof |
| 03/18/2003 | US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/18/2003 | US6534434 Chiral imidazolidinone-based catalyst composition and reaction system |
| 03/18/2003 | CA2223722C Keratin fibre oxidation dye composition and dye process using the composition |
| 03/13/2003 | WO2003020694A1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments |
| 03/13/2003 | WO2003020684A1 (alpha)-haloenamine reagents |
| 03/13/2003 | WO2003020263A1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity |
| 03/13/2003 | WO2003020256A1 Use of c2-substituted indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity |
| 03/13/2003 | WO2003020255A1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity |
| 03/13/2003 | WO2003020217A2 Novel pyrazole analogs acting on cannabinoid receptors |
| 03/13/2003 | WO2003020199A1 Use of derivatives of c2-substituted indan-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity |
| 03/13/2003 | WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/13/2003 | WO2002076950A3 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors |
| 03/13/2003 | WO2002053519A3 Hydrophobic polyamine analogs and methods for their use |
| 03/13/2003 | WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 03/13/2003 | WO2002022563A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 03/13/2003 | US20030050424 At least one isocyanate function modified with a group having crosslinking functional arm |
| 03/13/2003 | US20030050330 And inflammation-associated disorders, such as arthritis |
| 03/13/2003 | US20030050314 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/13/2003 | US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter |